Astria Therapeutics, Inc. - Common Stock (ATXS)

Shares of Rumble Inc.

ATXS stock results show that Astria Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

ATXS stock results show that Astria Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and board changes. Lifecore Biomedical shares dipped 31.7% to $4.91 on Wednesday.

ATXS stock results show that Astria Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.

Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.

Cantor Fitzgerald cut Hyliion Holdings Corp. (NYSE: HYLN) price target from $2 to $1. Cantor Fitzgerald analyst Andres Sheppard downgraded the stock from Neutral to Underweight. Hyliion shares fell 1.4% to $0.6449 in pre-market trading.

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.

U.S. stocks traded lower, with the Dow Jones dropping over 400 points on Thursday. Here are some big stocks recording gains in today’s session.

Although US stocks closed sharply higher on Wednesday, there were a few notable insider trades.

Morgan Stanley cut VTEX (NYSE: VTEX) price target from $7 to $5.  Morgan Stanley analyst Cesar Medina downgraded the stock from Overweight to Equal-Weight. VTEX shares fell 4.9% to close at $3.52 on Friday.

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 800 points.

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.